<DOC>
	<DOCNO>NCT00000674</DOCNO>
	<brief_summary>To collect information effectiveness toxicity clindamycin plus pyrimethamine leucovorin calcium treatment acute toxoplasmic encephalitis adult patient AIDS . Toxoplasmic encephalitis ( encephalitis cause Toxoplasma gondii ) frequent cause focal central nervous system infection patient AIDS . If untreated , encephalitis fatal . At present , standard practice give combination pyrimethamine sulfadiazine treat toxoplasmic encephalitis . The high frequency sulfonamide-induced toxicity AIDS patient often make completion full course therapy difficult . There information high dose parenteral ( injection ) clindamycin use pyrimethamine may effective pyrimethamine plus sulfadiazine management acute phase toxoplasmic encephalitis patient AIDS . Administration parenteral clindamycin prolong period time , however , costly , require hospitalization , inconvenient patient . There indication treatment AIDS patient acute toxoplasmic encephalitis oral clindamycin may effective . Leucovorin calcium useful prevent pyrimethamine-associated bone marrow toxicity .</brief_summary>
	<brief_title>A Pilot Study Oral Clindamycin Pyrimethamine Treatment Toxoplasmic Encephalitis Patients With AIDS</brief_title>
	<detailed_description>Toxoplasmic encephalitis ( encephalitis cause Toxoplasma gondii ) frequent cause focal central nervous system infection patient AIDS . If untreated , encephalitis fatal . At present , standard practice give combination pyrimethamine sulfadiazine treat toxoplasmic encephalitis . The high frequency sulfonamide-induced toxicity AIDS patient often make completion full course therapy difficult . There information high dose parenteral ( injection ) clindamycin use pyrimethamine may effective pyrimethamine plus sulfadiazine management acute phase toxoplasmic encephalitis patient AIDS . Administration parenteral clindamycin prolong period time , however , costly , require hospitalization , inconvenient patient . There indication treatment AIDS patient acute toxoplasmic encephalitis oral clindamycin may effective . Leucovorin calcium useful prevent pyrimethamine-associated bone marrow toxicity . Amended : Projected accrual increase 50 patient . Original design : Patients receive study medication total 6 week unless intervene event require discontinuation study therapy . Patients initially treat hospital ( minimum 7 day ) . Patients consider responder day 7 may complete therapy outpatient basis . Nonresponders day 7 may also manage outpatient basis medically appropriate .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Toxoplasmosis</mesh_term>
	<mesh_term>Toxoplasmosis , Cerebral</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Erythropoietin . Aerosolized pentamidine prophylaxis Pneumocystis carinii pneumonia ( PCP ) . Immunoglobulin therapy . Alpha interferon . Patients enter study isoniazid ( INH ) may continue INH therapy . Use corticosteroid discourage . If corticosteroid need management intracranial hypertension cranial mass effect , use dexamethasone encourage ( 4 g orally 4 time daily 3 day thereafter taper next 10 14 day ) . Patients admit study : Laboratory evidence HIV infection undetermined HIV infection status belong highrisk group HIV infection . Either definite presumptive diagnosis toxoplasmic encephalitis . Patient appropriate family member , legal designee must able understand sign write informed consent . Allowed : HIV encephalopathy . AMENDED : Allows patient relapse . Patients previous diagnosis toxoplasmic encephalitis base histopathology document neuroradiological response pyrimethamine sulfonamide pyrimethamine clindamycin relapse toxoplasmic encephalitis . Relapse must document definite progression lesion appearance new lesion compatible toxoplasmic encephalitis . Prior Medication : Allowed liver enzyme stable 6 week prior study entry : Rifampin . Isoniazid . Exclusion Criteria Coexisting Condition : Patients follow exclude : Infections central nervous system . Malabsorption syndrome ( 3 loose stool day least 4 week associate unintentional weight loss least 10 percent body weight ) . History sensitivity study medication . Malignancies require use cytotoxic chemotherapy . Coma . Diffuse central white matter lesion . Negative serology Toxoplasma perform Palo Alto Medical Foundation ( unless biopsy positive ) . Lymphoma central nervous system . Cerebral Kaposi 's sarcoma . Hemorrhagic diathesis active bleeding disorder . Concurrent Medication : Excluded : Erythromycin macrolides . Sulfonamides . Immunomodulators . Cytotoxic chemotherapy . Amphotericin . Dapsone . Rifamycins . Ganciclovir . Allopurinol . Antifolates . Azidothymidine antiretrovirals investigational agent specifically allow . Folate supplement . Isoniazid ( INH ) therapy may start therapy . Concurrent Treatment : Excluded : Lymphocyte replacement . Patients follow excluded : Negative HIV antibody federally license ELISA ( determine study entry ) , unless documentation previously positive HIV culture p24 antigen . Coma . Diffuse central white matter lesion . Negative serology Toxoplasma perform Palo Alto Medical Foundation ( unless biopsy positive ) . Lymphoma central nervous system . Cerebral Kaposi 's sarcoma . Hemorrhagic diathesis active bleeding disorder . Unable take oral medication reliably . Any medical social condition , opinion investigator , would adversely affect either participation and/or compliance study . Prior Medication : Excluded : Treatment toxoplasmic encephalitis .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Toxoplasmosis</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pyrimethamine</keyword>
	<keyword>Leucovorin</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Encephalitis</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Clindamycin</keyword>
</DOC>